EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
EXOZYMES INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$4.00−0.09 (-2.20%)
Close on Oct 19, 2026
- Market cap
- $34.64M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Exozymes has not reported a dividend
No dividend per share appears in Exozymes's annual filings since fiscal 2022.